Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 5, 2005 - Issue 4
Submit an article Journal homepage
174
Views
13
CrossRef citations to date
0
Altmetric
Review

Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs

Karen N Keating Global HEOR Bayer Pharmaceuticals Corporation, 400 Morgan Lane, West Haven, CT 06516, USA. [email protected]
,
Eleanor M Perfetto THE WEINBERG GROUP INC., 1220 Nineteenth Street, NW, Suite 300; Washington, DC 20036, USA. [email protected]
&
Prasun Subedi Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, 515 West Lombard Street No. 272, Baltimore, MD 21202-1563, USA. [email protected]
Pages 457-466 | Published online: 09 Jan 2014

References

  • Nicolle LE. Epidemiology of urinary tract infections. Infect. Med.18, 153–162 (2001).
  • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49, 53–70 (2003).
  • Foxman B, Barlow R, D’Arcy H et al. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10(8), 509–515 (2000).
  • Foxman B, Brown P. Epidemiology of urinary tract infections. Transmission and risk factors, incidence and costs. Infect. Dis. Clin. North Am. 17, 227–241 (2003).
  • Sotelo T, Westney OL. Recurrent urinary tract infections in women. Curr. Womens Health Rep. 3, 313–318 (2003).
  • Schappert SM. Ambulatory care visits to physician offices, hospital out-patient departments, and emergency departments US, 1997. Vital Health Stat. 143(13), i-iv, 1–39 (1999).
  • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(1A), S5–S13 (2002).
  • Hooton T. Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents 17, 259–268 (2001).
  • Rosenberg M. Pharmacoeconomics of treating uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 11, 247–251 (1999).
  • Gold MR, Siegel JE, Russle LB, Weinsteing MC. In: Cost-Effectiveness in Health and Medicine. Oxford University Press, NY, USA (1996).
  • Vogenberg, FR. In: Introduction to Applied Pharmacoeconomics. McGraw-Hill, NY, USA (2001).
  • Baerheim A, Digranes A, Jureen R, Malterud K. Generalized symptoms in adult women with acute uncomplicated lower urinary tract infection: an observational study. MedGenMed. 5(3), 1 (2003).
  • Colgan R, Keating K, Dougouih M. Survey of symptom burden in women with uncomplicated urinary tract infections. Clin. Drug Invest. 24(1), 55–60 (2004).
  • Baerheim A, Digranes A, Hunkskaar S. Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. Scand. J. Prim. Health Care17, 170–173 (1999).
  • Ellis A. Quality of life in women with urinary tract infections: is benign disease a misnomer? J. Am. Board Fam. Pract. 13(6), 392–397 (2000).
  • Foxman B, Frerichs R. Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. Am. J. Pub. Health 75, 1308–1313 (1985).
  • Klimberg I, Shockey G, Ellison H et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr. Med. Res. Opin. 21(8), 1241–1250 (2005).
  • Malterud K, Baerheim A. Peeing barbed wire: symptom experiences in women with lower urinary tract infection. Scand. J. Prim. Health Care17, 49–53 (1999).
  • Moller L, Lose G, Jorgensen T. The prevalence and bothersomeness of lower urinary tract symptoms in women 40–60 years of age. Acta Obstet. Gynecol. Scand. 79, 298–305 (2000).
  • Hooton TM. The current management strategies for community acquired urinary tract infection. Infect. Dis. Clin. North Am. 17, 303–332 (2003).
  • Perfetto EM, Keating K, Merchant S, Nichols B. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy. J. Manag. Care Pharm. 10(1), 17–25 (2004).
  • Katz J, Melzack R. Measurement of pain. Surg. Clin. North Am.79(2), 231–252 (1999).
  • Blondeau J. Current issues in the management of urinary tract infections. Extended-release ciprofloxacin as a novel treatment option. Drugs64(6), 611–628 (2004).
  • Sanson-Fischer R, Bowman J, Armstrong S. Factors affecting nonadherence with antibiotics. Diagn. Microbiol. Infect. Dis.15, S103–S109 (1992).

Websites

  • US Department of Labor. Bureau of Labor Statistics. 2002–2012 Employment Predictions. www.bls.gov/news.release/ecopro.nr0.htm (Accessed July 2005).
  • National Library of Medecine www.ncbi.nlm.nih.gov/entrez/query.fcgi (Accessed July 2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.